XXXIst diabetes days with international participation
Authors:
Peter Novodvorský 1,2,3
Authors‘ workplace:
metabolické centrum s. r. o., Trenčín
1; Centrum diabetologie IKEM, Praha
2; Department of Oncology and Metabolism, Medical School, University of Sheffield, United Kingdom
3
Published in:
Diab Obez 2021; 21(42): 109-110
Category:
News
Labels
Diabetology ObesitologyArticle was published in
Diabetes and obesity
2021 Issue 42
-
All articles in this issue
- Slovak diabetology – history, contemporary and future
- New possibility in therapy of diabetes mellitus: co-formulation of insulin degludec and insulin aspart
- Compensation of social consequences of diabetes mellitus
- News in the field of SGLT2 inhibitors
- Interesting (and not much discussed) aspects relevant for the choice of basal insulin
- GLP-1 receptors treatment: case reports
- Tortuous path of insulin discovery
- Report from the Symposium on technology in diabetology in Slovakia
- 81. virtual conference of American Diabetes Association 2021
- What is the message of the virtual European Congress of Cardiology in August 2021 on the role of new antidiabetic drugs in the treatment of heart failure?
- XXXIst diabetes days with international participation
- Diabetes and obesity
- Journal archive
- Current issue
- About the journal
Most read in this issue
- New possibility in therapy of diabetes mellitus: co-formulation of insulin degludec and insulin aspart
- Compensation of social consequences of diabetes mellitus
- News in the field of SGLT2 inhibitors
- XXXIst diabetes days with international participation